# StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients

> **NCT05073172** · NA · WITHDRAWN · sponsor: **OHSU Knight Cancer Institute**

## Conditions studied

- Breast Carcinoma
- Head and Neck Carcinoma
- Radiation-Induced Dermatitis

## Interventions

- **DRUG:** Calendula Ointment
- **OTHER:** Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment
- **OTHER:** Polyethylene Glycol Hydrogel
- **DRUG:** Silicone-based Film Forming Topical Gel
- **DRUG:** Silver Sulfadiazine
- **DRUG:** Topical Hydrocortisone

## Key facts

- **NCT ID:** NCT05073172
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-07-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** study staff transition
- **Last updated:** 2024-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05073172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05073172, "StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05073172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*